These analyses, coupled with the observation that serum IFN-γ levels were higher in protected group than in non-protected group, most distinctly one day after the final (third) dose suggested that the IFN-γ pathway may have a role in protection against parasitemia. The gene discussed is IFNG; the disease is parasitic infectious disease.